1. Short title This Act may be cited as the Timely Access to Clinical Treatment Act of 2023 or the TACT Act of 2023 . 2. Patient access to oral medications (a) In general Section 2719A of the Public Health Service Act ( 42 U.S.C. 300gg–19a ) is amended by adding at the end the following new subsection: (f) Access to oral medications (1) Requirements for contracts between group health plans or health insurance issuers and pharmacies If a group health plan or a health insurance issuer offering group or individual health insurance coverage covers or provides any benefits for oral medications (as defined in paragraph (4)) and enters into a contract with a pharmacy, whether directly or through an agent of such plan or issuer (including a pharmacy benefits manager) to dispense such medications to participants, beneficiaries, or enrollees of the plan or coverage, such plan or issuer shall require, as conditions of such contract, such pharmacy to carry out the procedures described in paragraph (2). (2) Procedures described For purposes of paragraph (1), the procedures described in this paragraph with respect to a participant, beneficiary, or enrollee of the plan or coverage and a health care provider who submits to such pharmacy a prescription for an oral medication for such participant, beneficiary, or enrollee are the following (as applicable): (A) Pharmacy confirmation of ability to dispense Not later than 24 hours after receiving such prescription— (i) confirm to such health care provider that such pharmacy received such prescription